0001596783-17-000180.txt : 20171213 0001596783-17-000180.hdr.sgml : 20171213 20171213143726 ACCESSION NUMBER: 0001596783-17-000180 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171211 FILED AS OF DATE: 20171213 DATE AS OF CHANGE: 20171213 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Chiminski John R CENTRAL INDEX KEY: 0001482197 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36587 FILM NUMBER: 171253618 MAIL ADDRESS: STREET 1: C/O CATALENT, INC. STREET 2: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Catalent, Inc. CENTRAL INDEX KEY: 0001596783 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208737688 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 BUSINESS PHONE: (732) 537-6200 MAIL ADDRESS: STREET 1: 14 SCHOOLHOUSE ROAD CITY: SOMERSET STATE: NJ ZIP: 08873 FORMER COMPANY: FORMER CONFORMED NAME: PTS Holdings Corp. DATE OF NAME CHANGE: 20140113 4 1 wf-form4_151319383198307.xml FORM 4 X0306 4 2017-12-11 0 0001596783 Catalent, Inc. CTLT 0001482197 Chiminski John R C/O CATALENT, INC. 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 1 1 0 0 Chair, President & CEO Common Stock 2017-12-11 4 M 0 206685 10.71 A 536766 D Common Stock 2017-12-11 4 F 0 125227 39.70 D 411539 D Common Stock 2017-12-11 4 S 0 81458 39.70 D 330081 D Common Stock 2017-12-11 4 S 0 21810 39.70 D 308271 D Common Stock 2017-12-12 4 S 0 78190 39.51 D 230081 D Options to purchase Common Stock 10.71 2017-12-11 4 M 0 206685 0 D 2019-10-23 Common Stock 206685.0 0 D This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017 in order to implement a plan of financial diversification. Includes restricted stock units. Represents shares withheld to pay the exercise price and applicable withholding taxes associated with the exercise of stock options pursuant to the Rule 10b5-1 trading plan noted in footnote (1). Weighted average price. These shares were sold in multiple transactions at prices ranging from $39.42 to $40.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (4), (5), and (6) to this Form 4. Weighted average price. These shares were sold in multiple transactions at prices ranging from $39.61 to $39.75, inclusive. Weighted average price. These shares were sold in multiple transactions at prices ranging from $39.21 to $39.86, inclusive. On October 23, 2009, the reporting person was granted options to purchase common stock of the Issuer, which options began to vest and become exercisable upon the passage of time (and, in certain cases, the satisfaction of performance criteria) beginning October 23, 2010. All options have vested and been exercised or have been cancelled as of the date of this Form 4. /s/ Jose Ibietatorremendia, attorney-in-fact 2017-12-13